Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dennis Thomas

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|May 27, 2026
A Real-World Controlled Multicentre Study Evaluating the Association Between Benralizumab Therapy and Major Outcomes in Severe AsthmaDennis Thomas, Vanessa M McDonald, Gijo Thomas, et al.
Respirology (Carlton, Vic.)|May 23, 2025
Unlocking Asthma Remission: Key Insights From an Expert Roundtable DiscussionDennis Thomas, Hayley Lewthwaite, Peter G Gibson, et al.
BMJ Open|December 19, 2023
A novel, multidomain, primary care nurse-led and mHealth-assisted intervention for dementia risk reduction in middle-aged adults (HAPPI MIND): study protocol for a cluster randomised controlled trialAmanda J Cross, Gopisankar Mohanannair Geethadevi, Parker Magin, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 7, 2025
Identifying dementia risk profiles for targeted interventions: A latent class analysis of at-risk middle-aged AustraliansMuhammad Rehan Sarwar, Amanda J Cross, Kali Godbee, et al.
Respiratory Medicine|September 5, 2025
Mepolizumab treatment and reduced oral corticosteroid exposure improves symptoms of depression and anxiety in severe eosinophilic asthma: data from the Australian Mepolizumab RegistryErin S Harvey, Yuto Hamada, Sarah A Hiles, et al.
Allergy|August 26, 2023
Biologics (mepolizumab and omalizumab) induced remission in severe asthma patientsDennis Thomas, Vanessa M McDonald, Sean Stevens, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 5, 2021
Mepolizumab and Oral Corticosteroid Stewardship: Data from the Australian Mepolizumab RegistryDennis Thomas, Erin S Harvey, Vanessa M McDonald, et al.
Medrxiv : the Preprint Server for Health Sciences|August 17, 2021
SARS-CoV-2 Seroprevalence and Drug Use in Trauma Patients from Six Sites in the United StatesTran B Ngo, Maria Karkanitsa, Kenneth M Adusei, et al.
Environmental Health Perspectives|April 30, 2021
CATMoS: Collaborative Acute Toxicity Modeling SuiteKamel Mansouri, Agnes L Karmaus, Jeremy Fitzpatrick, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|May 27, 2026
A Real-World Controlled Multicentre Study Evaluating the Association Between Benralizumab Therapy and Major Outcomes in Severe AsthmaDennis Thomas, Vanessa M McDonald, Gijo Thomas, et al.
Respirology (Carlton, Vic.)|May 23, 2025
Unlocking Asthma Remission: Key Insights From an Expert Roundtable DiscussionDennis Thomas, Hayley Lewthwaite, Peter G Gibson, et al.
BMJ Open|December 19, 2023
A novel, multidomain, primary care nurse-led and mHealth-assisted intervention for dementia risk reduction in middle-aged adults (HAPPI MIND): study protocol for a cluster randomised controlled trialAmanda J Cross, Gopisankar Mohanannair Geethadevi, Parker Magin, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 7, 2025
Identifying dementia risk profiles for targeted interventions: A latent class analysis of at-risk middle-aged AustraliansMuhammad Rehan Sarwar, Amanda J Cross, Kali Godbee, et al.
Respiratory Medicine|September 5, 2025
Mepolizumab treatment and reduced oral corticosteroid exposure improves symptoms of depression and anxiety in severe eosinophilic asthma: data from the Australian Mepolizumab RegistryErin S Harvey, Yuto Hamada, Sarah A Hiles, et al.
Allergy|August 26, 2023
Biologics (mepolizumab and omalizumab) induced remission in severe asthma patientsDennis Thomas, Vanessa M McDonald, Sean Stevens, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 5, 2021
Mepolizumab and Oral Corticosteroid Stewardship: Data from the Australian Mepolizumab RegistryDennis Thomas, Erin S Harvey, Vanessa M McDonald, et al.
Medrxiv : the Preprint Server for Health Sciences|August 17, 2021
SARS-CoV-2 Seroprevalence and Drug Use in Trauma Patients from Six Sites in the United StatesTran B Ngo, Maria Karkanitsa, Kenneth M Adusei, et al.
Environmental Health Perspectives|April 30, 2021
CATMoS: Collaborative Acute Toxicity Modeling SuiteKamel Mansouri, Agnes L Karmaus, Jeremy Fitzpatrick, et al.
Pageof 8